Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Aptevo Therapeutics: Q3 Earnings Insights

Aptevo Therapeutics (NASDAQ:APVO) reported its Q3 earnings results on Tuesday, November 14, 2023 at 08:00 AM. Here’s what…
byBenzinga Insights
November 14, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Aptevo Therapeutics (NASDAQ:APVO) reported its Q3 earnings results on Tuesday, November 14, 2023 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Aptevo Therapeutics beat estimated earnings by 33.33%, reporting an EPS of $-0.5 versus an estimate of $-0.75.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 3.43% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Aptevo Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Verizon’s Q1: Flat Revenue, Bump In Free Cash Flow And Stable 2024 Outlook

By Anusuya Lahiri
April 22, 9:01 AM
Verizon Communications Inc. announces slight sales growth in Q1 2024, hitting $32.98 billion, with adjusted EPS topping expectations at $1.15. Despite missing sales consensus, wireless service revenue rose by 3.3% year-on-year, driven by strategic pricing and subscriber growth. The company sees strong broadband additions and reiterates optimistic financial guidance for the year.

DJD